Stem Point Capital LP Ark Genomic Revolution ETF (De Transaction History
Stem Point Capital LP
- $401 Billion
- Q4 2024
A detailed history of Stem Point Capital LP transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Stem Point Capital LP holds 5,000 shares of ARKG stock, worth $123,100. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$123,100% of portfolio
0.1%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding ARKG
# of Institutions
285Shares Held
23.3MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$89.3 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$85.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$68.7 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$68.5 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$40.8 Million0.02% of portfolio